These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
789 related articles for article (PubMed ID: 24687988)
1. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice. Li X; Xing Y; Guo L; Lv X; Song H; Xi T Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988 [TBL] [Abstract][Full Text] [Related]
2. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model. Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori. Xing Y; Liu W; Li X; Guo L; Lv X; Xi T Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137 [TBL] [Abstract][Full Text] [Related]
5. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model. Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457 [TBL] [Abstract][Full Text] [Related]
6. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883 [TBL] [Abstract][Full Text] [Related]
7. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB. Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model. Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640 [TBL] [Abstract][Full Text] [Related]
9. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit. Guo L; Li X; Tang F; He Y; Xing Y; Deng X; Xi T Appl Microbiol Biotechnol; 2012 Mar; 93(5):1937-45. PubMed ID: 22134639 [TBL] [Abstract][Full Text] [Related]
10. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model. Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Protection Against Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K Front Immunol; 2019; 10():1185. PubMed ID: 31191547 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection. Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746 [TBL] [Abstract][Full Text] [Related]
13. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies. Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734 [TBL] [Abstract][Full Text] [Related]
14. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach. Meza B; Ascencio F; Sierra-Beltrán AP; Torres J; Angulo C Infect Genet Evol; 2017 Apr; 49():309-317. PubMed ID: 28185986 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism. Lv X; Yang J; Song H; Li T; Guo L; Xing Y; Xi T Vaccine; 2014 Sep; 32(41):5343-52. PubMed ID: 25093281 [TBL] [Abstract][Full Text] [Related]
17. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Zhao W; Wu W; Xu X Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305 [TBL] [Abstract][Full Text] [Related]
18. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes. Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255 [TBL] [Abstract][Full Text] [Related]
19. Protection Against Pan X; Ke H; Niu X; Li S; Lv J; Pan L Front Immunol; 2018; 9():1003. PubMed ID: 29867978 [TBL] [Abstract][Full Text] [Related]
20. A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice. Sun N; Zhang R; Duan G; Peng X; Wang C; Chen S; Fan Q Biotechnol Lett; 2019 Dec; 41(12):1415-1421. PubMed ID: 31620902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]